Interim Report on the Safety and Efficacy of Longer-Term Treatment with Nusinersen in Infantile-Onset Spinal Muscular Atrophy (SMA): Updated Results from the SHINE Study
Neurology(2019)
Key words
Neuromuscular Disorders,Rare Diseases
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined